公开(公告)号：MX2015005118A

公开(公告)日：2015-10-29

申请号：MX2015005118

申请日：2013-10-21

Applicant: BAXTER INT

Inventor： CHEN YE ,  TITUS JOEL ,  ROHDE JUSTIN ,  WHITE JEFF ,  DING SAMUEL ,  COOPER KEVIN ,  MALIEKKAL SHINCY

IPC: G01N33/18 ,  A61M1/16 ,  G01N27/416

Abstract: Se proveen un sistema y método para determinar una concentración de cloro total en el agua de diálisis. El sistema comprende una unidad principal que aloja una cámara de yoduro/muestra de agua y una cámara de agente reductor. Un par de electrodos puentea las dos cámaras y genera triyoduro proporcional a la cantidad de calor total en el agua de diálisis. El par de electrodos detecta la cantidad de triyoduro generado en proporción a la cantidad de cloruro activo en el agua de diálisis. El sistema es apropiado para uso en conexión con, o para incorporación en, un sistema de purificación de agua para generar fluido de diálisis, y puede incluir una pantalla que alerta al usuario a detener o evitar un tratamiento de hemodiálisis si el nivel de cloro total excede un nivel predeterminado.

公开(公告)号：AU2014242274A1

公开(公告)日：2015-10-01

申请号：AU2014242274

申请日：2014-02-14

Applicant: BAXTER INT ,  BAXTER HEALTHCARE SA

Inventor： LIN RONGSHENG ,  DING YUANPANG SAMUEL ,  WHITE JAMES M ,  CHEN YE ,  LO YING-CHENG ,  MILLER JOSHUA ,  ROHDE JUSTIN

IPC: A61M1/16

Abstract: Systems and methods for hemodialysis or peritoneal dialysis having integrated electrodialysis and electrodeionization capabilities are provided. In an embodiment, the dialysis system includes a carbon source, a urease source, an ED/EDI unit. The carbon source, urease source, and/or the ED/EDI unit can be in the form of removable cartridges.

公开(公告)号：DE112013005089T5

公开(公告)日：2015-07-16

申请号：DE112013005089

申请日：2013-10-21

Applicant: BAXTER HEALTHCARE SA ,  BAXTER INT

Inventor： WHITE JEFF ,  CHEN YE ,  TITUS JOEL ,  ROHDE JUSTIN ,  MALIEKKAL SHINCY ,  COOPER KEVIN ,  DING SAMUEL

IPC: G01N33/18 ,  G01N27/416

Abstract: Es werden ein System und Verfahren zum Bestimmen einer Konzentration von Gesamtchlor in Dialysewasser bereitgestellt. Das System umfasst ein Haupteinheitsgehäuse, eine KI/Wasserprobekammer und eine Natriumsulfatkammer. Ein erstes Elektrodenpaar überbrückt die zwei Kammern und erzeugt Tri-Jodid proportional zur Menge an Gesamtchlor in der Wasserprobe. Ein zweites Elektrodenpaar in Kontakt mit Fluid in der KI/Wasserprobe weist eine Menge an Tri-Jodid nach, die vom ersten Elektrodenpaar erzeugt wird. Das System ist zur Verwendung in Verbindung mit, oder zur Eingliederung in ein Wasserreinigungssystem geeignet, um Dialysefluid zu erzeugen, und kann eine Anzeige enthalten, die den Anwender benachrichtigt, eine Hämodialysebehandlung zu stoppen oder zu verhindern, wenn der Gesamtchlorpegel einen vorbestimmten Pegel überschreitet.

公开(公告)号：GB2522158A

公开(公告)日：2015-07-15

申请号：GB201508559

申请日：2013-10-21

Applicant: BAXTER INT ,  BAXTER HEALTHCARE SA

Inventor： WHITE JEFF ,  CHEN YE ,  DING SAMUEL ,  TITUS JOEL ,  ROHDE JUSTIN ,  MALIEKKAL SHINCY ,  COOPER KEVIN

IPC: G01N27/416 ,  G01N33/18

Abstract: A system and method for determining a concentration of total chlorine in dialysis water are provided. The system comprises a main unit housing an iodide/water sample chamber and a reducing agent chamber. An electrode pair bridges the two chambers and generates tri-iodide proportional to the amount of total chlorine in the dialysis water. The electrode pair detects the amount of tri-iodide generated in proportion to the amount of active chloride in the dialysis water. The system is suitable for use in connection with, or for incorporation into, a water purification system for generating dialysis fluid, and may include a display that alerts the user to stop or prevent a hemodialysis treatment if the total chlorine level exceeds a predetermined level.

公开(公告)号：CA2889059A1

公开(公告)日：2014-05-01

申请号：CA2889059

申请日：2013-10-21

Applicant: BAXTER INT ,  BAXTER HEALTHCARE SA

Inventor： WHITE JEFF ,  CHEN YE ,  DING SAMUEL ,  TITUS JOEL ,  ROHDE JUSTIN ,  MALIEKKAL SHINCY ,  COOPER KEVIN

IPC: G01N33/18 ,  G01N27/416

Abstract: A system and method for determining a concentration of total chlorine in dialysis water are provided. The system comprises a main unit housing a KI/water sample chamber and a sodium sulfate chamber. A first electrode pair bridges the two chambers and generates tri-iodide proportional to the amount of total chlorine in the water sample. A second electrode pair in contact with fluid in the KI/water sample detects an amount of tri-iodide generated by the first electrode pair. The system is suitable for use in connection with, or for incorporation into, a water purification system for generating dialysis fluid, and may include a display that alerts the user to stop or prevent a hemodialysis treatment if the total chlorine level exceeds a predetermined level.

公开(公告)号：MX386140B

公开(公告)日：2025-03-18

申请号：MX2015005118

申请日：2015-04-22

Applicant: BAXTER INT ,  BAXTER HEALTHCARE SA

Inventor： WHITE JEFF ,  TITUS JOEL ,  ROHDE JUSTIN ,  COOPER KEVIN ,  DING SAMUEL ,  SHINCY MALIEKKAL ,  CHEN YE

IPC: G01N33/18 ,  A61M1/16 ,  G01N27/416

Abstract: Se proveen un sistema y método para determinar una concentración de cloro total en el agua de diálisis. El sistema comprende una unidad principal que aloja una cámara de yoduro/muestra de agua y una cámara de agente reductor. Un par de electrodos puentea las dos cámaras y genera triyoduro proporcional a la cantidad de calor total en el agua de diálisis. El par de electrodos detecta la cantidad de triyoduro generado en proporción a la cantidad de cloruro activo en el agua de diálisis. El sistema es apropiado para uso en conexión con, o para incorporación en, un sistema de purificación de agua para generar fluido de diálisis, y puede incluir una pantalla que alerta al usuario a detener o evitar un tratamiento de hemodiálisis si el nivel de cloro total excede un nivel predeterminado.

公开(公告)号：ES2982111T3

公开(公告)日：2024-10-14

申请号：ES16197425

申请日：2007-09-11

Applicant: BAXTER INT INC ,  BAXTER HEALTHCARE SA

Inventor： LO YING-CHENG ,  CHILDERS ROBERT W ,  KELLY THOMAS D ,  ROHDE JUSTIN

IPC: A61M1/16 ,  A61M1/28 ,  A61M1/34

公开(公告)号：AU2021202238B2

公开(公告)日：2022-07-21

申请号：AU2021202238

申请日：2021-04-14

Applicant: BAXTER HEALTHCARE SA ,  BAXTER INT

Inventor： ROHDE JUSTIN ,  WIEBENSON DEREK

IPC: B08B3/02

Abstract: A renal therapy apparatus includes a blood filter including a plurality of hollow fiber membranes, arterial and venous lines in fluid communication with the blood filter, a blood pump for pumping blood through the arterial and venous lines and the blood filter, a treatment fluid pump in fluid communication with (a) a treatment fluid side of the blood filter or (b) the arterial or venous lines, and a control unit configured to control the blood pump and the treatment fluid pump during treatment and at least one of the blood pump or the treatment fluid pump during a filter cleaning sequence in which (i) in a first phase of the filter cleaning sequence, a first fluid including a blood-compatible and physiologically safe fluid is transferred back and forth across the insides and/or outsides of the plurality of hollow fiber membranes, (ii) after the first phase, a second fluid is formed by mixing the first fluid with air, and (iii) in a second phase of the filter cleaning sequence, the second fluid is transferred across the insides and/or outsides of the plurality of hollow fiber membranes at least one time, wherein the use of the first and second fluids including the physiologically safe fluid enables the filter cleaning sequence to be performed, if desired, during the treatment. 1AIA/n21

公开(公告)号：AU2021202238A1

公开(公告)日：2021-05-13

申请号：AU2021202238

申请日：2021-04-14

Applicant: BAXTER HEALTHCARE SA ,  BAXTER INT

Inventor： ROHDE JUSTIN ,  WIEBENSON DEREK

IPC: B08B3/02

Abstract: A renal therapy apparatus includes a blood filter including a plurality of hollow fiber membranes, arterial and venous lines in fluid communication with the blood filter, a blood pump for pumping blood through the arterial and venous lines and the blood filter, a treatment fluid pump in fluid communication with (a) a treatment fluid side of the blood filter or (b) the arterial or venous lines, and a control unit configured to control the blood pump and the treatment fluid pump during treatment and at least one of the blood pump or the treatment fluid pump during a filter cleaning sequence in which (i) in a first phase of the filter cleaning sequence, a first fluid including a blood-compatible and physiologically safe fluid is transferred back and forth across the insides and/or outsides of the plurality of hollow fiber membranes, (ii) after the first phase, a second fluid is formed by mixing the first fluid with air, and (iii) in a second phase of the filter cleaning sequence, the second fluid is transferred across the insides and/or outsides of the plurality of hollow fiber membranes at least one time, wherein the use of the first and second fluids including the physiologically safe fluid enables the filter cleaning sequence to be performed, if desired, during the treatment. 1AIA/n21

公开(公告)号：AU2019279913A1

公开(公告)日：2020-01-16

申请号：AU2019279913

申请日：2019-12-09

Applicant: BAXTER HEALTHCARE SA ,  BAXTER INT

Inventor： ROHDE JUSTIN ,  WIEBENSON DEREK

IPC: B08B3/02

Abstract: A renal therapy apparatus includes a blood filter including a plurality of hollow fiber membranes, arterial and venous lines in fluid communication with the blood filter, a blood pump for pumping blood through the arterial and venous lines and the blood filter, a treatment fluid pump in fluid communication with (a) a treatment fluid side of the blood filter or (b) the arterial or venous lines, and a control unit configured to control the blood pump and the treatment fluid pump during treatment and at least one of the blood pump or the treatment fluid pump during a filter cleaning sequence in which (i) in a first phase of the filter cleaning sequence, a first fluid including a blood-compatible and physiologically safe fluid is transferred back and forth across the insides and/or outsides of the plurality of hollow fiber membranes, (ii) after the first phase, a second fluid is formed by mixing the first fluid with air, and (iii) in a second phase of the filter cleaning sequence, the second fluid is transferred across the insides and/or outsides of the plurality of hollow fiber membranes at least one time, wherein the use of the first and second fluids including the physiologically safe fluid enables the filter cleaning sequence to be performed, if desired, during the treatment. Q/12/210f